Hold Parameters for Metoprolol and Diltiazem
Hold metoprolol if heart rate <50 bpm with worsening symptoms, or if systolic blood pressure <90 mmHg with symptomatic hypotension; hold diltiazem if heart rate <50 bpm, systolic blood pressure <90 mmHg, or in the presence of decompensated heart failure or greater than first-degree AV block.
Metoprolol Hold Parameters
Heart Rate Criteria
- Hold if HR <50 bpm AND patient has worsening symptoms (increasing dyspnea, fatigue, edema) 1
- If severe deterioration occurs, stop the beta-blocker entirely (though this is rarely necessary)
- Halve the dose first before considering complete discontinuation 1
- Arrange ECG to exclude heart block when bradycardia is present 1
Blood Pressure Criteria
- Hold if symptomatic hypotension (dizziness, lightheadedness, confusion) with low blood pressure 1
- Asymptomatic low blood pressure does NOT require holding the medication 1
- Systolic BP <90 mmHg is a precaution for use 2, 3
Additional Contraindications
- AV block greater than first-degree or SA node dysfunction (without pacemaker) 2, 3
- Decompensated systolic heart failure 2, 3
- Cardiogenic shock 4
- Reactive airway disease/bronchospasm 2, 4
Critical Safety Note
Never stop beta-blockers abruptly unless absolutely necessary - there is significant risk of rebound myocardial ischemia, infarction, and arrhythmias 1. Seek specialist advice before discontinuation when possible.
Diltiazem (Cardizem) Hold Parameters
Heart Rate Criteria
- Hold if HR <50 bpm 1
- Review need for other heart rate-slowing drugs (digoxin, amiodarone, verapamil) when bradycardia occurs 1
- Diltiazem prolongs AH conduction time and AV node refractory periods by approximately 20% 5
Blood Pressure Criteria
- Hold if systolic BP <90 mmHg (hypotension is a major precaution) 2, 3, 4
- Hypotension is a common adverse effect, occurring in 10-19% of patients 6, 7
Cardiac Function Criteria
- Hold in decompensated systolic heart failure or severe LV dysfunction 2, 3, 2
- Diltiazem has negative inotropic effects and is potentially harmful in heart failure 1
- However, recent evidence suggests short-term use may be safe in HFrEF patients with close monitoring 8
Conduction System Criteria
- Hold if AV block greater than first-degree or SA node dysfunction (without pacemaker) 2, 3, 2
- In sick sinus syndrome, diltiazem can prolong sinus cycle length up to 50% 5
- Avoid in WPW syndrome with atrial fibrillation/flutter 2, 3
Hepatic/Renal Dysfunction
- Use caution and consider holding in significant hepatic or renal dysfunction 3
- Hepatic impairment increases half-life and AUC by 69% 5
Comparative Safety Considerations
Recent meta-analyses reveal important differences between these agents:
- Metoprolol has 26% lower risk of adverse events overall compared to diltiazem (10% vs 19% incidence) 6
- Diltiazem achieves better rate control but with higher hypotension risk (RR 1.43) 9
- No significant difference in bradycardia rates between the two agents 6, 10
- Patients with higher initial heart rates face increased adverse event rates with both drugs 6
Clinical Algorithm for Holding Decision
- Check vital signs: HR and BP are your primary decision points
- Assess symptoms: Symptomatic bradycardia or hypotension mandates holding
- Review cardiac function: Decompensated HF requires immediate hold of diltiazem
- Check ECG: Look for AV block or conduction abnormalities
- Consider drug interactions: Both drugs interact with other AV nodal blockers 1
Common pitfall: Holding medications for asymptomatic low blood pressure - this is unnecessary and may compromise rate control 1. Only symptomatic hypotension requires intervention.